Peptides that induce antibodies which neutralize genetically divergent HIV-1 isolates

US5756674A · kind A · utility

Assignee

• Herman Katinger · AT

Inventors

• Hermann Katinger · Wien, AT
• Florian Ruker · Wien, AT
• Gottfried Himmler · Groß-Enzersdorf, AT
• Thomas Muster · Wien, AT
• Alexandra Trkola · Wien, AT
• Martin Purtscher · Wien, AT
• Georg Maiwald · Wien, AT
• Franz Steindl · Wien, AT

Key dates

• Filing date: Jun 7, 1995
• Grant date: May 26, 1998
• Expiry date: Jun 7, 2015

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to fusion peptides wherein at least one peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 25 is bound to an adjuvant being a protein molecule by fusion of the respective nucleotide sequences and subsequent expression of the fusion genes in a biological expression system.